Skip Navigation

Adalvo and Aristo Pharma sign licensing & supply agreement to commercialise a basket of products

25 November 2022

Adalvo is pleased to announce that it has entered into a partnership with Aristo Pharma, to commercialize several dermatology products. This licensing and supply agreement includes a basket of five products covering several dermatology indications including, acne, rosacea, psoriasis and atopic dermatitis.

Anil Okay, CEO at Adalvo comments: “We are proud to be partnering with Aristo Pharma; this latest agreement allows us to step into a unique domain that is not pursued by many players in the industry. This enhances our ability to offer differentiated, value-added products to our partners.”

Christian Jaaks, CEO at Aristo Pharma comments: “This basket deal underlines the importance of the strategic partnership we have built in the last couple of years with Adalvo. We are proud to increase our presence in the dermatology sector in the European pharmaceutical market, which is fully in line with the company’s group strategy. We look forward with great excitement to the next months ahead whilst we continue to expand our portfolio for medical promotion products.”


About Adalvo

Adalvo is a global pharmaceutical company, and one of the leading B2B pharmaceutical companies in Europe, with commercial partnerships in more than 100 countries and for over 110 commercial partners globally. The company’s declared purpose is to make a difference for patients all over the world, driven by our smart collaboration network and commitment to delivering highest quality differentiated products and services to our partners.

With headquarters in Malta, the company has additional offices in more than 16 countries. At Adalvo, we know that our partners like to be bigger, better, and smarter in the dynamic pharmaceutical sector. That’s why our approach is unique, customized to our partners, and is designed to challenge the status quo: together, this helps our partners achieve their business goals.

We take pride in our ability to help its partners reach their goals – be those increasing revenues or pushing into new markets. While partners are a high priority, Adalvo is also committed to its purpose and mission to accelerate the growth and development of employees and local communities. Adalvo tirelessly strives for excellence in all of its endeavors, driven by a deep-rooted passion to making a difference for partners.

The company’s purpose driven culture is committed to improving the lives of patients around the world. Our dynamic leadership team brings significant experience and industry know-how to Adalvo, which has helped to establish the company as a reliable global partner.

About Aristo Pharma

Aristo Pharma, established in 2008, is one of the fastest growing pharmaceutical companies in Europe covering most of the European markets.

As a vertical integrated company, we are operating five state of the art manufacturing facilities in Germany and Spain.

With our 1,700 highly motivated employees and our 12 sales and marketing locations, Aristo Pharma promotes high standard pharmaceutical products and medical devices to doctors, pharmacies and wholesalers across Europe.